Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
10/2002
10/03/2002WO2002060276A9 Combination of probiotics
10/03/2002WO2002046226A3 Trefoil factor 2 (tff2) peptides with moiety attached to asn15
10/03/2002WO2002014349A3 Non-covalent inhibitors of urokinase and blood vessel formation
10/03/2002WO2001093836A3 Encapsulation of polynucleotides and drugs into targeted liposomes
10/03/2002WO2001071004A3 Proteases
10/03/2002WO2001021812A9 Phosphatases which activate map kinase pathways
10/03/2002WO2001019800A9 Mediators of hedgehog signaling pathways, compositions and uses related thereto
10/03/2002WO1998036745A3 Use of polyunsaturated fatty acids for reducing the incidence of necrotizing enterocolitis
10/03/2002US20020143145 Detcting moduators of binding activity of preferential membrane proteins; obtain animal, incubate with modulator, monitor adjustment in activity from recptors
10/03/2002US20020143055 Administering an effective amount of propionoyloxymethyl propionate, butyroyloxymethyl butyrate, or mixtures for therapy of illness
10/03/2002US20020143043 For therapy and prophylaxis of rheumatoid arthritis, or of allergic disorders, asthma, inflammation; inhibitors of the adhesion and migration of leucocytes and/or antagonists of adhesion receptor VLA-4 belonging to the integrins group
10/03/2002US20020143036 Pentafluorobenzenesulfonamides and analogs
10/03/2002US20020143032 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
10/03/2002US20020143027 As inhibitors of tumor necrosis factor; for therapy of cachexia, arthritis, rheumatoid arthritis, osteoarthritis, reperfusion injury, congestive heart failure, Crohn's disease, ulcerative colitis, systemic lupus erythrematosis
10/03/2002US20020143026 Induce mitotic arrest thereby making them useful as anti-cancer agents; also for therapy of diseases which can be treated by inducing mitotic arrest
10/03/2002US20020143020 Novel piperazine derivatives
10/03/2002US20020143008 CRF receptor antagonists and methods relating thereto
10/03/2002US20020143004 Allosteric adenosine receptor modulators
10/03/2002US20020142986 Used in the diagnosis or prognosis of liver associated disorders
10/03/2002US20020142983 MUC-1 antagonists and methods of treating immune disorders
10/03/2002US20020142943 A drug and an agent capable of inducing the dephosphorylation of phosphorylated serine and/or threonine residue of p100 and/or p120, wherein the ability of the drug to cross a physiological barrier is improved.
10/03/2002US20020142436 Enzymatic protein for use in the treatment of tumors, nervous system, cardiovascular, psychological, pregnancy, bone, kidney, respiratory and alimentary canal disorders
10/03/2002US20020142353 Connective tissue growth factor (CTGF) and methods of use
10/03/2002US20020142054 Laxative; anticholesterol agents
10/03/2002US20020142045 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
10/03/2002US20020142041 Gastrointestinal mucosa-adherent matrixes, pharmaceutical preparations and a coating composition
10/03/2002US20020142034 Orally disintegrable tablets
10/03/2002US20020141977 Immunotherapy based on dendritic cells
10/03/2002US20020141970 Stabilized with chelate compound; storage stability
10/03/2002CA2692295A1 Combined use of methylol-transfer agents and fas-ligands in the treatment of cancer
10/03/2002CA2442576A1 Bioactivity of methyl palmitate obtained from a mangrove plant salvadora persica l
10/03/2002CA2442178A1 2-amino-propanol derivatives
10/03/2002CA2441806A1 Inosine compounds and their use for treating or preventing an inflammation or a reperfusion disease
10/03/2002CA2441700A1 Polypeptides and nucleic acids for bolekine
10/03/2002CA2441599A1 Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain
10/03/2002CA2441577A1 Therapeutic agents for inflammatory bowel diseases
10/03/2002CA2441568A1 Pharmaceutical combinations for the treatment of cancer
10/03/2002CA2441455A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors
10/03/2002CA2441377A1 Protein phosphate inhibitors
10/03/2002CA2441092A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/03/2002CA2440676A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
10/03/2002CA2440389A1 Aminopyrrolidine sulfonamides as serine protease inhibitors
10/03/2002CA2439961A1 Human cytokine receptor
10/03/2002CA2439678A1 Uses of opg ligand to modulate immune responses
10/03/2002CA2436351A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/02/2002EP1245676A1 Human monoclonal antibodies against tgf-beta ii receptor and medicinal use thereof
10/02/2002EP1245580A1 Fibre containing composition for enteral nutrition
10/02/2002EP1245568A1 Sulfonyl derivatives of amino acids and their use as inhibitors of dipeptidyl-peptidase IV (DPP IV)
10/02/2002EP1245562A1 5-THIA-$g(v)-(SUBSTITUTED PHENYL)-PROSTAGLANDIN E ALCOHOLS, PROCESS FOR PREPARING THE ALCOHOLS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME AS THE ACTIVE INGREDIENT
10/02/2002EP1245236A1 Preventives and remedies for chronic hepatitis
10/02/2002EP1245231A2 Pharmaceutical formulations containing darifenacin
10/02/2002EP1245229A2 Methods and compositions for inhibition of angiogenesis
10/02/2002EP1244790A2 Nucleic acids encoding polypeptides having chips activity
10/02/2002EP1244784A2 Methods and compositions for inhibiting neoplastic cell growth
10/02/2002EP1244781A2 Antisense oligonucleotides
10/02/2002EP1244780A2 Dna encoding the human serine protease t
10/02/2002EP1244773A1 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof
10/02/2002EP1244700A2 Vesicle trafficking proteins
10/02/2002EP1244693A1 Compositions for treating abnormalities in glomerular filtration, patent ductus arteriosus and osteoporosis
10/02/2002EP1244686A1 Transforming growth factor alpha hiii
10/02/2002EP1244683A1 21 human secreted proteins
10/02/2002EP1244678A1 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b)
10/02/2002EP1244677A1 Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b)
10/02/2002EP1244672A1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
10/02/2002EP1244669A1 Pyrazolopyrazines and their use as adenosine antagonists
10/02/2002EP1244666A1 Imidazopyrimidinyl and imidazopyridinyl derivatives
10/02/2002EP1244657A2 Sulfonamides and derivatives thereof that modulate the activity of endothelin
10/02/2002EP1244653A1 Non peptide tachykinin receptor antagonists
10/02/2002EP1244649A1 Cyclic amp-specific phosphodiesterase inhibitors
10/02/2002EP1244643A1 Tryptase inhibitors
10/02/2002EP1244641A1 Thiazolyl amide derivatives
10/02/2002EP1244628A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
10/02/2002EP1244626A2 Caspase inhibitors and uses thereof
10/02/2002EP1244625A1 4-pyridinyl-n-acyl-l-phenylalanines
10/02/2002EP1244620A1 Cyclic amp-specific phosphodiesterase inhibitors
10/02/2002EP1244619A1 Pyrrolidines which inhibit camp-specific pde
10/02/2002EP1244616A1 (hetero)bicyclylmethanesulfonylamino-substituted hydroxamic acid derivatives
10/02/2002EP1244614A2 Tryptase inhibitors
10/02/2002EP1244469A2 Mutant simplex virus for treating unwanted hyperproliferative cell growth
10/02/2002EP1244461A2 INHIBITION OF GSK-3$g(b)
10/02/2002EP1244458A2 Weight promoting composition, method, and product
10/02/2002EP1244451A1 Substituted piperazine and piperidine calcium channel blockers
10/02/2002EP1244448A2 Novel methods for the treatment and prevention of ileus
10/02/2002EP1244447A2 Novel methods and compositions involving opioids and antagonists thereof
10/02/2002EP1244440A1 Agonists specific for the peripheral cannabinoid receptor
10/02/2002EP1244439A1 Oral glutamine in the prevention of neonatal necrotizing enterocolitis and other gastrointestinal mucosal damage
10/02/2002EP1244434A2 Use of chemotherapeutic agents
10/02/2002EP1244356A1 Compositions and methods for l-nucleosides, l-nucleotides, and their analogs
10/02/2002EP1098648B1 Pharmaceutical compositions comprising hydroxylansoprazole and uses thereof
10/02/2002EP1077068B9 Utilization of interferon alpha 5 in the treatment of viral hepatopathies
10/02/2002EP0804196B1 Use of serotonin antagonists (5ht 3) for treating fibromyalgia
10/02/2002EP0793503B1 Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells
10/02/2002DE10108122A1 Arzneimittel auf Basis von Tramadol Medicines based on tramadol
10/02/2002CN1372570A Modified exendin and exendin agonists
10/02/2002CN1372569A Keratinocyte growth factor-2
10/02/2002CN1372563A Oxathiepino [6,5-b] dihydropyridines, and related compositions and methods
10/02/2002CN1372562A Imidazoimidazoles and triazoles as anti-inflammatory agents
10/02/2002CN1372557A Neurotrophin production/secretion promoting agent
10/02/2002CN1372555A Compositions and therapeutic mehtods involving isoflavones and analogues thereof
10/02/2002CN1372547A Aminoalkoxy carbazoles for the treatment of CNS diseases
1 ... 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 ... 1258